Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Announces Dividend Increase – $0.11 Per Share

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) announced a quarterly dividend on Friday, December 20th,NASDAQ Dividends reports. Stockholders of record on Friday, December 20th will be paid a dividend of 0.112 per share on Tuesday, December 24th. This represents a $0.45 annualized dividend and a dividend yield of 1.79%. The ex-dividend date is Friday, December 20th. This is a boost from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.001.

Fidelity Disruptive Medicine ETF Trading Up 1.0 %

Shares of FMED stock traded up $0.26 during trading hours on Friday, reaching $25.03. The stock had a trading volume of 6,359 shares, compared to its average volume of 5,417. The stock’s fifty day simple moving average is $25.87 and its 200 day simple moving average is $25.30. The firm has a market capitalization of $52.56 million, a PE ratio of 35.73 and a beta of 0.94. Fidelity Disruptive Medicine ETF has a 12 month low of $23.22 and a 12 month high of $26.68.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.